Product Overview

Tirzepatide is a synthetic 39-amino acid peptide studied as a dual agonist, meaning it engages two metabolic receptor pathways at once: GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1). That dual-pathway design is what separates Tirzepatide from single-agonist peptides and why it appears so often in current metabolic research literature.

Each NXTSTATE vial contains 20mg of lyophilized Tirzepatide powder, tested by an independent third-party laboratory before it reaches inventory. The lab report for this lot is published on this page. Check it before you buy.

Research Background

Tirzepatide has been examined across multiple published metabolic and endocrine studies, with research models focusing on receptor signaling, glucose regulation pathways, and energy balance mechanisms. Its dual-receptor profile has made it a frequent reference compound in comparative peptide research alongside single-pathway agonists.

Researchers commonly compare Tirzepatide against Retatrutide and Semaglutide when studying how different receptor combinations behave. See our Research Notes for that comparison.

Product Specifications

• Purity: 99.469% (HPLC verified, lot tested)
• Measured quantity: 20.71mg (label claim 20mg)
• Form: Lyophilized powder
• Appearance: White to off-white powder
• Storage: Store lyophilized vials at -20C. Protect from light.
• Shipping: Ships from the US, typically within 24 hours

Quality Assurance

Every lot of Tirzepatide is tested by an independent third-party lab for identity, quantity, and purity by RP-HPLC with UV detection. We publish the actual report, not a badge or a claim. The current lot returned 99.469% purity and 20.71mg measured content against a 20mg label claim.

If a company will not show you the lab report before you buy, that tells you something. Ours is on this page.

Reconstitution and Handling

Tirzepatide is supplied as a lyophilized powder and is typically reconstituted with bacteriostatic water for laboratory use. Add solvent slowly against the vial wall and allow the powder to dissolve without shaking. Store reconstituted material refrigerated and protected from light. Bacteriostatic water and syringes are available separately.

Why Researchers Study Tirzepatide

Single agonist peptides engage one receptor pathway. Tirzepatide engages two, and that is the entire reason it occupies the position it does in current metabolic literature. For a researcher building a comparison, dual agonism is a variable you cannot isolate with a single pathway compound, so Tirzepatide has become the standard reference point when the question is how combined receptor signaling behaves against single receptor signaling.

Its 39 amino acid structure and fatty acid modification also make it a frequent subject in half life and stability research. Published Tirzepatide literature is indexed on PubMed under tirzepatide if you want to read the primary sources yourself before ordering.

Storage and Stability

Lyophilized material is stable for extended periods when stored correctly. Keep unopened vials at -20C, protected from light, and let a vial reach room temperature before opening it so condensation does not form on the powder. Once reconstituted, Tirzepatide should be refrigerated at 2C to 8C and kept away from light. Avoid repeated freeze and thaw cycles, which degrade peptides faster than storage temperature alone.

Handle vials gently. Peptides in solution are sensitive to mechanical stress, so swirl rather than shake, and do not vortex the solution.

Compliance and Disclaimers

This product is sold for laboratory and research use only. It is not a drug, food, or cosmetic and is not intended for human or veterinary consumption, diagnosis, treatment, or prevention of any condition. Purchasers must be qualified researchers or institutions and assume full responsibility for safe handling, storage, and lawful use.

For Research Use Only. Not for human consumption.